JP2002525317A5 - - Google Patents

Download PDF

Info

Publication number
JP2002525317A5
JP2002525317A5 JP2000571905A JP2000571905A JP2002525317A5 JP 2002525317 A5 JP2002525317 A5 JP 2002525317A5 JP 2000571905 A JP2000571905 A JP 2000571905A JP 2000571905 A JP2000571905 A JP 2000571905A JP 2002525317 A5 JP2002525317 A5 JP 2002525317A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
composition according
moxifloxacin
salt
concentration
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2000571905A
Other languages
English (en)
Japanese (ja)
Other versions
JP2002525317A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US1999/022622 external-priority patent/WO2000018386A2/en
Publication of JP2002525317A publication Critical patent/JP2002525317A/ja
Publication of JP2002525317A5 publication Critical patent/JP2002525317A5/ja
Pending legal-status Critical Current

Links

JP2000571905A 1998-09-30 1999-09-29 眼、耳および鼻治療用の抗生物質組成物 Pending JP2002525317A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US10250498P 1998-09-30 1998-09-30
US10250698P 1998-09-30 1998-09-30
US60/102,506 1998-09-30
US60/102,504 1998-09-30
PCT/US1999/022622 WO2000018386A2 (en) 1998-09-30 1999-09-29 Antibiotic compositions for treatment of the eye, ear and nose

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2008213954A Division JP2009007375A (ja) 1998-09-30 2008-08-22 眼、耳および鼻治療用の抗生物質組成物

Publications (2)

Publication Number Publication Date
JP2002525317A JP2002525317A (ja) 2002-08-13
JP2002525317A5 true JP2002525317A5 (enExample) 2007-07-05

Family

ID=26799441

Family Applications (5)

Application Number Title Priority Date Filing Date
JP2000571905A Pending JP2002525317A (ja) 1998-09-30 1999-09-29 眼、耳および鼻治療用の抗生物質組成物
JP2008213954A Withdrawn JP2009007375A (ja) 1998-09-30 2008-08-22 眼、耳および鼻治療用の抗生物質組成物
JP2012002159A Withdrawn JP2012067141A (ja) 1998-09-30 2012-01-10 眼、耳および鼻治療用の抗生物質組成物
JP2012242519A Expired - Lifetime JP5563041B2 (ja) 1998-09-30 2012-11-02 眼、耳および鼻治療用の抗生物質組成物
JP2014103658A Pending JP2014144982A (ja) 1998-09-30 2014-05-19 眼、耳および鼻治療用の抗生物質組成物

Family Applications After (4)

Application Number Title Priority Date Filing Date
JP2008213954A Withdrawn JP2009007375A (ja) 1998-09-30 2008-08-22 眼、耳および鼻治療用の抗生物質組成物
JP2012002159A Withdrawn JP2012067141A (ja) 1998-09-30 2012-01-10 眼、耳および鼻治療用の抗生物質組成物
JP2012242519A Expired - Lifetime JP5563041B2 (ja) 1998-09-30 2012-11-02 眼、耳および鼻治療用の抗生物質組成物
JP2014103658A Pending JP2014144982A (ja) 1998-09-30 2014-05-19 眼、耳および鼻治療用の抗生物質組成物

Country Status (18)

Country Link
EP (5) EP2301541B1 (enExample)
JP (5) JP2002525317A (enExample)
KR (1) KR101463243B1 (enExample)
CN (2) CN1184968C (enExample)
AR (2) AR020661A1 (enExample)
AT (2) ATE501732T1 (enExample)
AU (1) AU762827B2 (enExample)
BR (1) BRPI9914151B1 (enExample)
CA (3) CA2342211C (enExample)
CY (3) CY1111404T1 (enExample)
DE (2) DE69943287D1 (enExample)
DK (5) DK2796138T3 (enExample)
ES (4) ES2519190T3 (enExample)
HK (1) HK1038691B (enExample)
PT (5) PT1384478E (enExample)
TR (2) TR200100883T2 (enExample)
TW (1) TWI222361B (enExample)
WO (1) WO2000018386A2 (enExample)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6395746B1 (en) 1998-09-30 2002-05-28 Alcon Manufacturing, Ltd. Methods of treating ophthalmic, otic and nasal infections and attendant inflammation
US6716830B2 (en) 1998-09-30 2004-04-06 Alcon, Inc. Ophthalmic antibiotic compositions containing moxifloxacin
AR020661A1 (es) 1998-09-30 2002-05-22 Alcon Lab Inc Una composicion farmaceutica topica oftalmica, otica o nasal y el uso de la misma para la manufactura de un medicamento
US6509327B1 (en) * 1998-09-30 2003-01-21 Alcon Manufacturing, Ltd. Compositions and methods for treating otic, ophthalmic and nasal infections
DE19937115A1 (de) * 1999-08-06 2001-02-08 Bayer Ag Wäßrige Arzneimittelformulierung von Moxifloxacin oder Salzen davon
DE19937116A1 (de) * 1999-08-06 2001-02-08 Bayer Ag Moxifloxacin Kochsalzformulierung
DE60006262T2 (de) 1999-09-24 2004-05-13 Alcon, Inc. Topische suspensionsformulierungen enthaltend ciprofloxacin und dexamethason
DE19962470A1 (de) 1999-12-22 2001-07-12 Schulz Hans Herrmann Verwendung von Chemotherapeutika
AU2001261748A1 (en) * 2000-05-19 2001-12-03 Alcon Laboratories Inc. Antibiotic compositions for treatment of the eye, ear and nose
CA2412575C (en) 2000-07-26 2009-12-29 Onkar N. Singh Improved process for manufacturing compositions containing ciprofloxacin and hydrocortisone
AU2002214308A1 (en) * 2000-11-16 2002-05-27 Wakamoto Pharmaceutical Co., Ltd. Antibacterial gel eye drops
WO2002049633A2 (en) 2000-12-20 2002-06-27 Alcon, Inc. Use of amidoamines to treat or prevent acanthamoeba and fungal infections
WO2002049627A2 (en) * 2000-12-20 2002-06-27 Alcon, Inc. Antifungal compositions containing an antibiotic and one or more amidoamines
US20030139382A1 (en) 2001-09-21 2003-07-24 Alcon, Inc. Method of treating middle ear infections
US7220431B2 (en) 2002-11-27 2007-05-22 Regents Of The University Of Minnesota Methods and compositions for applying pharmacologic agents to the ear
PL1666477T3 (pl) 2003-09-10 2013-11-29 Kyorin Seiyaku Kk Pochodna kwasu 7-(4-podstawionego-3-cyklopropyloaminometylo-1- pirolidynylo)chinolonokarboksylowego
WO2006015545A1 (fr) * 2004-08-11 2006-02-16 Shenzhen Tys R & D Co., Ltd. Capsule de gelatine de moxifloxacin et procede pour sa preparation
US20080124385A1 (en) * 2004-09-03 2008-05-29 Piedmont Pharmaceuticals,Llc. Methods for Transmembrane Treatment and Prevention of Otitis Media
DE102005055385A1 (de) * 2004-12-09 2006-06-14 Bayer Healthcare Ag Arzneimittel zur hygienischen Applikation im Ohr
EP1824499A2 (en) * 2004-12-10 2007-08-29 Alcon Inc. Compositions for treatment of ear infections
CN101317847B (zh) * 2007-06-06 2010-10-13 深圳市瑞谷医药技术有限公司 一种眼用或耳鼻用药物组合物及其用途
TWI544934B (zh) 2008-06-09 2016-08-11 愛爾康研究有限公司 含有氟喹諾酮抗生素藥物之經改良藥學組成物
JP5784012B2 (ja) * 2009-07-02 2015-09-24 アルコン リサーチ， リミテッド 眼、耳または鼻の感染症を処置するためのフィナフロキサシンを含む組成物および方法
LT2521547T (lt) * 2010-01-07 2017-12-11 Regents Of The University Of Minnesota Moksifloksacino vartojimo į ausį būdai ir kompozicijos
WO2013085769A1 (en) 2011-12-06 2013-06-13 Alcon Research, Ltd. Cellulosic gel composition with improved viscosity stability
RU2472507C1 (ru) * 2012-02-01 2013-01-20 Закрытое акционерное общество "Брынцалов-А" Водный состав на основе моксифлоксацина для парентерального введения
US9504691B2 (en) * 2012-12-06 2016-11-29 Alcon Research, Ltd. Finafloxacin suspension compositions
US20150164882A1 (en) 2013-07-22 2015-06-18 Imprimis Pharmaceuticals, Inc. Pharmaceutical compositions for intraocular administration and methods for fabricating thereof
US20160279055A1 (en) 2013-07-22 2016-09-29 Imprimis Pharmaceuticals, Inc. Pharmaceutical ophthalmic compositions for intraocular administration and methods for fabricating thereof
CN104224802B (zh) * 2014-09-19 2017-12-12 南京优科生物医药研究有限公司 一种盐酸莫西沙星滴耳剂及其制备方法
RU2595837C2 (ru) * 2014-09-29 2016-08-27 Открытое Акционерное Общество "Татхимфармпрепараты" Состав и способ получения глазных капель
EP3369422A4 (en) * 2015-10-29 2018-12-05 Teika Pharmaceutical Co., Ltd. External preparation
US12042500B2 (en) * 2018-04-03 2024-07-23 Hyderabad Eye Research Foundation Mucoadhesive drug delivery system for ocular administration of fluoroquinolone antibiotics
IT201900005280A1 (it) * 2019-04-05 2020-10-05 Ntc S R L Composizione otologica
JP2023530254A (ja) * 2020-06-10 2023-07-14 オキュラー サイエンス，インク． 手術後の眼科的ケアのための組成物および方法
CN116270662A (zh) * 2021-12-03 2023-06-23 苏州欧康维视生物科技有限公司 盐酸莫西沙星地塞米松磷酸钠滴眼液
KR102656260B1 (ko) 2022-10-14 2024-04-09 주식회사태준제약 목시플록사신을 포함하는 안과용 조성물

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5223493A (en) 1984-12-28 1993-06-29 Alcon Laboratories, Inc. Anti-inflammatory compounds for ophthalmic use
US4910225A (en) * 1988-01-27 1990-03-20 Senju Pharmaceutical Co., Ltd. Locally administrable therapeutic composition for inflammatory disease
DE3906365A1 (de) * 1988-07-15 1990-01-18 Bayer Ag 7-(1-pyrrolidinyl)-3-chinolon- und -naphthyridoncarbonsaeure-derivate, verfahren sowie substituierte (oxa)diazabicyclooctane und -nonane als zwischenprodukte zu ihrer herstellung, und sie enthaltende antibakterielle mittel und futterzusatzstoffe
AU4201189A (en) 1988-08-26 1990-03-23 Alcon Laboratories, Inc. Combination of quinolone antibiotics and steroids for topical ophthalmic use
JPH085779B2 (ja) * 1989-09-22 1996-01-24 杏林製薬株式会社 フレロキサシン点眼液
JPH03109236A (ja) * 1989-09-22 1991-05-09 Hoya Corp 半導体超微粒子分散ガラスの製造方法
TW209865B (enExample) * 1992-01-10 1993-07-21 Bayer Ag
DE69333850T3 (de) 1992-05-06 2011-03-17 Alcon Laboratories, Inc., Fort Worth Anwendung von boral-polyol-komplexen für ophthalmische arzneizusammensetzungen
DE4424369A1 (de) * 1994-07-11 1996-01-18 Bayer Ag Pyrido[3,2,1.i,j][3,1]benzoxazinderivate
JPH0892241A (ja) * 1994-09-22 1996-04-09 Ss Pharmaceut Co Ltd ５−ヒドラジノキノロンカルボン酸誘導体及びこれを有効成分とする抗菌剤
US5631287A (en) 1994-12-22 1997-05-20 Alcon Laboratories, Inc. Storage-stable prostaglandin compositions
WO1996039146A1 (en) * 1995-06-06 1996-12-12 Bayer Corporation Non-irritation, non-sensitizing, non-ototoxic otic antibacterial compositions
JP3290914B2 (ja) * 1997-03-17 2002-06-10 参天製薬株式会社 眼組織におけるキノロン系抗菌剤の定量装置
BR9812553B1 (pt) * 1997-09-25 2010-06-01 formulação medicamentosa em pélete de difusão controlada e em um sistema matriz.
WO2000016736A1 (en) 1998-09-23 2000-03-30 Unilever N.V. Oral care compositions
AR020661A1 (es) 1998-09-30 2002-05-22 Alcon Lab Inc Una composicion farmaceutica topica oftalmica, otica o nasal y el uso de la misma para la manufactura de un medicamento
KR20010107754A (ko) * 2000-05-26 2001-12-07 민경윤 경구투여용 속용정의 제조 방법

Similar Documents

Publication Publication Date Title
KR101463243B1 (ko) 눈, 귀 및 코 치료용 항생제 조성물
US6716830B2 (en) Ophthalmic antibiotic compositions containing moxifloxacin
WO2000018388A2 (en) Antibiotic compositions for treatment of the eye, ear and nose
JP2012520882A5 (enExample)
JP2002525326A (ja) 眼、耳および鼻治療用の抗生物質組成物
AU2003248033B2 (en) Antibiotic Compositions for Treatment of the Eye, Ear and Nose
ES2360792T3 (es) Composiciones de antibiótico que contienen moxifloxacina para el tratamiento del ojo.
AU2007201610A1 (en) Antibiotic compositions for treatment of the eye, ear and nose
MXPA01003293A (en) Antibiotic compositions for treatment of the eye, ear and nose
MXPA01003294A (en) Antibiotic compositions for treatment of the eye, ear and nose
HK1150769B (en) Antibiotic compositions for treatment of the eye